Epizyme (EPZM) PT Lowered to $16 at Oppenheimer
Tweet
Share
E-mailGet Alerts EPZM Hot Sheet
Price: $1.47 --0%
Rating Summary:
8 Buy, 5 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 2 | Down: 9 | New: 19
Rating Summary:
8 Buy, 5 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 2 | Down: 9 | New: 19
Join SI Premium – FREE
Oppenheimer analyst Leland Gershell lowered the price target on Epizyme (NASDAQ: EPZM) to $16.00 (from $18.00) while maintaining a Outperform rating.
You May Also Be Interested In
- Morgan Stanley Assumes Wise plc (WISE:LN) (WPLCF) at Equalweight
- Snowflake Inc. (SNOW) PT Raised to $470 at Morgan Stanley
- Antin Infrastructure Partners SA (ANTIN:FP) PT Raised to EUR8.70 at Morgan Stanley
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
